The steak on the plate is not the only living thing that met an antibiotic this year. Medically important antibiotics sold for U.S. livestock jumped 16 percent in 2024, according to the Food and Drug Administration, reversing years of relatively stable farm sales. That is not a farm trivia item. It is a resistance story that ends in human hospitals.
When the same drug classes used to save people are also used to keep industrial herds standing, bacteria get extra rehearsal. The rehearsal is going well for the bacteria.
How much antibiotic is used in U.S. livestock?
FDA’s Center for Veterinary Medicine publishes an annual summary of antimicrobials sold or distributed for food-producing animals. The 2024 report said sales of medically important drugs — the ones that matter in human medicine — rose 16 percent from 2023. The agency noted this was a break from the generally stable pattern since 2017. Total volume was still 27 percent below the 2015 peak, which is the honest context. The peak was enormous. A rebound off a lower plateau is still a rebound.
Tetracyclines remain a large share of what is sold for animals and rose about 20 percent year over year. Aminoglycoside sales jumped 37 percent. Macrolides, another class used in people, ticked up. Penicillins fell 14 percent. By species, reporting for 2024 put roughly 43 percent of medically important sales with swine, 41 percent with cattle, and 16 percent with poultry. Those are sales shares, not a moral ranking. They tell you where the pharmaceutical volume sits.
The big drop after 2015 was not a mystery. Growth-promotion indications for medically important antibiotics were withdrawn, and veterinary oversight expanded. Those were the right moves. They were not a finish line. Biomass-adjusted figures, which account for the size of the animal population, also rose in 2024 for several classes. More drug per pound of animal is the opposite of stewardship.
The FDA is careful to say that sales are not a complete diary of why a drug was used. That caution cuts both ways. We know the products are moving through the system. We still lack a transparent, farm-level account of treatment versus convenience.
Why does livestock antibiotic use threaten people?
Resistance does not respect the fence line. Campylobacter, Salmonella, and other foodborne bacteria have been tracked for years in retail meat and in people. When a drug that treats a human infection is also used in feed or water for thousands of animals, selection pressure is a numbers game. The farm can function as a bioreactor. The grocery store is part of the distribution system.
None of this requires you to swear off meat. It requires you to stop pretending “raised with antibiotics” is a purely veterinary issue. Animals get sick. Sick animals may need treatment. Routine use in crowded production is a different sentence. If a product can be produced without medically important drugs as a management tool, that is the product that belongs in a resistance strategy.
Organic standards and some third-party programs restrict those uses. Front-of-pack slogans are only as good as the certifier. “Antibiotic free” on a dead animal is also a sloppy phrase; the useful claim is about how the living animal was raised. Read who is verifying, not just the font size of the promise.
What can shoppers do about farm antibiotics?
- Prefer meat and dairy with a verifiable no-routine-antibiotics claim, not a slogan invented in a marketing meeting.
- Cook poultry and ground meat to a safe internal temperature. Resistance does not make kitchen hygiene optional.
- Do not demand antibiotics from your own clinician for a viral cold. Stewardship starts in barns and in exam rooms.
- Ask cafeterias, schools, and grocers which suppliers they use. Volume buyers move markets faster than a single cart.
The FDA can publish spreadsheets. It cannot make a confinement system less dependent on pharmaceutical crutches. Every time medically important sales climb, the production model is telling you it still needs the drugs. Buy as if that message were printed on the package. It might as well be.